Literature DB >> 29674015

Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer.

Yufei Liu1, Chang Wang1, Ran Wang1, Yike Wu1, Liang Zhang1, Bi-Feng Liu1, Liming Cheng2, Xin Liu3.   

Abstract

Glycosylation is one of the most important post-translational modifications of protein. Recently, global profiling of human serum glycomics has become a noninvasive method for cancer-related biomarker discovery and many studies have focused on compositional glycan profiling. In contrast, structure-specific glycan profiling may provide more potential biomarkers with higher specificity than compositional profiling. In this work, N-glycans released from human serum were neutralized with methylamine and reduced by ammonia-borane complex prior to profiling using nanoLC-ESI-MS with porous graphitized carbon (PGC) and relative abundances of over 280 isomers were compared between pancreatic cancer (PC) cases (n = 32) and healthy controls (n = 32). Statistical analysis identified 25 specific-isomeric biomarkers with significant differences (p-value < 0.05). ROC and PCA analysis were performed to assess the potential biomarkers which were identified as being significantly altered in cancer. The AUCs of the significantly changed specific-isomers were ranging from 0.712 to 0.949. In addition, with the combination of all potential biomarkers, a higher AUC of 0.976 with sensitivity (93.5%) and specificity (90.6%) was obtained. Overall, the proposed strategy coupled to relative quantitative analysis of isomeric glycans make it possible to discover new biomarkers for the diagnosis of PC. SIGNIFICANCE: Pancreatic cancer (PC) has a poor prognosis with a five-year survival rate <5%. Therefore, a strategy for accurate diagnosis of PC is indeed required. In this paper, a dual-derivatized strategy for structure-specific glycan profiling has been used and according to our best knowledge, this is the first application of this strategy for PC biomarker discovery, in which the separation, identification and relative quantification of isomeric glycans can be simultaneously obtained. In addition, by in-depth analysis of isomeric glycans, the full description of the stereo- and region- diversity of glycans can also be achieved, which might provide more potential information for PC biomarker discovery.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  N-glycans; PC; Potential biomarker; Specific-isomer

Mesh:

Substances:

Year:  2018        PMID: 29674015     DOI: 10.1016/j.jprot.2018.04.016

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  6 in total

1.  Desalting Paper Spay Mass Spectrometry (DPS-MS) for Rapid Detection of Glycans and Glycoconjugates.

Authors:  Kai-Yuan Chiu; Qi Wang; Harsha P Gunawardena; Michael Held; Ahmed Faik; Hao Chen
Journal:  Int J Mass Spectrom       Date:  2021-08-28       Impact factor: 1.986

2.  Identification a novel clinical biomarker in early diagnosis of human non-small cell lung cancer.

Authors:  Yanxia Jin; Yajun Yang; Yanting Su; Xiangdong Ye; Wei Liu; Qing Yang; Jie Wang; Xiangning Fu; Yongsheng Gong; Hui Sun
Journal:  Glycoconj J       Date:  2019-01-03       Impact factor: 2.916

3.  Characterization of glycan isomers using magnetic carbon nanoparticles as a MALDI co-matrix.

Authors:  Alireza Banazadeh; Reed Nieman; Mona Goli; Wenjing Peng; Ahmed Hussein; Ercan Bursal; Hans Lischka; Yehia Mechref
Journal:  RSC Adv       Date:  2019-06-27       Impact factor: 4.036

Review 4.  Targeting Glycans and Heavily Glycosylated Proteins for Tumor Imaging.

Authors:  Ruben D Houvast; Mireille Vankemmelbeke; Lindy G Durrant; Manfred Wuhrer; Victor M Baart; Peter J K Kuppen; Lioe-Fee de Geus-Oei; Alexander L Vahrmeijer; Cornelis F M Sier
Journal:  Cancers (Basel)       Date:  2020-12-21       Impact factor: 6.639

Review 5.  Glycomic and Glycoproteomic Techniques in Neurodegenerative Disorders and Neurotrauma: Towards Personalized Markers.

Authors:  Firas Kobeissy; Abir Kobaisi; Wenjing Peng; Chloe Barsa; Mona Goli; Ahmad Sibahi; Samer El Hayek; Samar Abdelhady; Muhammad Ali Haidar; Mirna Sabra; Matej Orešič; Giancarlo Logroscino; Stefania Mondello; Ali H Eid; Yehia Mechref
Journal:  Cells       Date:  2022-02-08       Impact factor: 6.600

Review 6.  Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review.

Authors:  Jinshou Yang; Ruiyuan Xu; Chengcheng Wang; Jiangdong Qiu; Bo Ren; Lei You
Journal:  Cancer Commun (Lond)       Date:  2021-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.